NDRA Investment Analysis: Ultrasound innovator targeting metabolic-disease diagnostics with quantitative liver fat “TAEUS”
※ ENDRA Life Sciences (NDRA) is developing Thermo Acoustic Enhanced Ultrasound (TAEUS®) to quantify liver fat (NAFLD/MASH). It holds CE mark in Europe but is not yet FDA 510(k)-cleared in the U.S. In 2025, the company is cutting costs, refocusing strategy, and positioning itself as a biomarker platform in the GLP-1 era, improving commercialization visibility. 😅 📖 Company OverviewBusiness: ENDR..
Korea Stock InBody (041830) Analysis: Growth Potential of a Global Healthcare & Body Composition Company
Korea Stock InBody (041830) Analysis: Growth Potential of a Global Healthcare & Body Composition Company※ In 2025, the global healthcare industry is rapidly expanding under the rise of digital healthcare and wellness trends.InBody (041830) is a leading global company specializing in body composition analyzers, supplying devices used in medical, fitness, and research fields while steadily expandi..
In-Depth Analysis of Know Labs Inc. (KNW) Stock: Price Drivers, Technical Trends, Future Value, and Investment Strategy
In-Depth Analysis of Know Labs Inc. (KNW) Stock: Price Drivers, Technical Trends, Future Value, and Investment Strategy※ Know Labs Inc. (NASDAQ: KNW) is an innovative medical technology company headquartered in Seattle, USA, specializing in non-invasive blood glucose measurement solutions and biosignal analysis.As the global healthcare industry rapidly transforms through digitalization and the e..